Keyphrases
Pediatric Patients
100%
Asthma
100%
Nasal Airway
100%
Bacterial Microbiota
100%
Children with Asthma
75%
Airway Microbiome
75%
Respiratory Illness
75%
Rhinovirus Infection
75%
Nasal
50%
Epithelial Damage
50%
Microbiota
50%
Moraxella
50%
Corynebacterium
50%
Nasal Microbiota
50%
Fall Season
50%
Moraxella Species
50%
Clinical Outcomes
25%
Staphylococcus Species
25%
Interleukin-8
25%
Interleukin-33 (IL-33)
25%
Damage Response
25%
Viral Infection
25%
Microbial Composition
25%
Inflammatory Response
25%
Statistical Analysis
25%
Childhood Asthma
25%
Exacerbation Risk
25%
Bacterial Isolates
25%
Anti-IgE
25%
Relative Abundance
25%
Inflammatory Cytokine Response
25%
Temporal Stability
25%
Asthma Development
25%
Eosinophil Activation
25%
Nasopharyngeal
25%
Omalizumab
25%
Haemophilus Spp
25%
Respiratory Exacerbation
25%
Acute Respiratory Tract Infection
25%
Corynebacterium Species
25%
Nasal Secretion
25%
Moraxella Catarrhalis
25%
Dominant Genera
25%
16S rRNA Gene Profiling
25%
Microbiota Assemblage
25%
A549 Epithelial Cells
25%
Alloiococcus
25%
Microbiota Structure
25%
Abundance Fluctuations
25%
Viral Exacerbation
25%
Immunology and Microbiology
Asthma
100%
Microflora
100%
Bacterial Flora
100%
Airway
100%
Moraxella
57%
Infection
57%
Rhinovirus
42%
Corynebacterium
42%
Streptococcus
28%
Interleukin-33
14%
Viral Disease
14%
Inflammation Response
14%
Taxon
14%
Eosinophil
14%
Inflammatory Cytokine
14%
Immunoglobulin E
14%
Haemophilus
14%
Omalizumab
14%
Nose Secretion
14%
Moraxella catarrhalis
14%
Interleukin 8
14%
In Vitro
14%
Ribosome RNA
14%
Ribosomal RNA
14%